366 related articles for article (PubMed ID: 17419948)
21. Characterization of primary breast carcinomas grown in three-dimensional cultures.
Becker JL; Blanchard DK
J Surg Res; 2007 Oct; 142(2):256-62. PubMed ID: 17727885
[TBL] [Abstract][Full Text] [Related]
22. An imageable metastatic treatment model of nasopharyngeal carcinoma.
Liu T; Ding Y; Xie W; Li Z; Bai X; Li X; Fang W; Ren C; Wang S; Hoffman RM; Yao K
Clin Cancer Res; 2007 Jul; 13(13):3960-7. PubMed ID: 17606730
[TBL] [Abstract][Full Text] [Related]
23. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.
Yates CC; Shepard CR; Stolz DB; Wells A
Br J Cancer; 2007 Apr; 96(8):1246-52. PubMed ID: 17406365
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer metastasis progression as revealed by intravital videomicroscopy.
MacDonald IC; Chambers AF
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1271-9. PubMed ID: 17020460
[TBL] [Abstract][Full Text] [Related]
25. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments.
Sasser AK; Mundy BL; Smith KM; Studebaker AW; Axel AE; Haidet AM; Fernandez SA; Hall BM
Cancer Lett; 2007 Sep; 254(2):255-64. PubMed ID: 17467167
[TBL] [Abstract][Full Text] [Related]
26. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
[TBL] [Abstract][Full Text] [Related]
27. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein.
Farina KL; Wyckoff JB; Rivera J; Lee H; Segall JE; Condeelis JS; Jones JG
Cancer Res; 1998 Jun; 58(12):2528-32. PubMed ID: 9635573
[TBL] [Abstract][Full Text] [Related]
28. [In vitro experimentation of a new model of radial flow bioreactor containing isolated hepatocytes].
Morsiani E; Puviani AC; Brogli M; Pazzi P; Tosatti S; Valieri L; Gorini P; Fogli L; Galavotti D; Borra M; Bellini C; Squarzoni P; Ricci D; Reverberi R; Azzena G
Ann Ital Chir; 2000; 71(3):337-45. PubMed ID: 11014013
[TBL] [Abstract][Full Text] [Related]
29. Involvement of bone marrow-derived stromal cells in gastrointestinal cancer development and metastasis.
Ishii S; Tsuji S; Tsujii M; Kanazawa Y; Nishida T; Iijima H; Yasumaru M; Irie T; Yamamoto K; Tsutsui S; Eguchi H; Kawano S; Hayashi N
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S242-9. PubMed ID: 19120906
[TBL] [Abstract][Full Text] [Related]
30. Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures.
Krishnan V; Shuman LA; Sosnoski DM; Dhurjati R; Vogler EA; Mastro AM
J Cell Physiol; 2011 Aug; 226(8):2150-8. PubMed ID: 21520067
[TBL] [Abstract][Full Text] [Related]
31. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
[TBL] [Abstract][Full Text] [Related]
32. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
33. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
34. Tissue engineered tumor models.
Ingram M; Techy GB; Ward BR; Imam SA; Atkinson R; Ho H; Taylor CR
Biotech Histochem; 2010 Aug; 85(4):213-29. PubMed ID: 20482463
[TBL] [Abstract][Full Text] [Related]
35. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
36. Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments.
Martín B; Sanz R; Aragüés R; Oliva B; Sierra A
J Proteome Res; 2008 Aug; 7(8):3242-53. PubMed ID: 18582095
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
38. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion.
Man YG
Med Hypotheses; 2007; 69(6):1340-57. PubMed ID: 17493765
[TBL] [Abstract][Full Text] [Related]
39. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.
Yang BW; Liang Y; Xia JL; Sun HC; Wang L; Zhang JB; Tang ZY; Liu KD; Chen J; Xue Q; Chen J; Gao DM; Wu WZ
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1077-84. PubMed ID: 19047839
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
